YALÇIN, Ş. Et Al. 2013. Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial. ONCOLOGY , vol.85, no.6 , 328-335.

YALÇIN, Ş., Uslu, R., Dane, F., Yilmaz, U., Zengin, N., Buyukunal, E., ... Buyukberber, S.(2013). Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial. ONCOLOGY , vol.85, no.6, 328-335.

YALÇIN, ŞUAYİB Et Al. "Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial," ONCOLOGY , vol.85, no.6, 328-335, 2013

YALÇIN, ŞUAYİB Et Al. "Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial." ONCOLOGY , vol.85, no.6, pp.328-335, 2013

YALÇIN, Ş. Et Al. (2013) . "Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial." ONCOLOGY , vol.85, no.6, pp.328-335.

@article{article, author={ŞUAYİB YALÇIN Et Al. }, title={Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial}, journal={ONCOLOGY}, year=2013, pages={328-335} }